TAIPEI, April 13, 2026 /PRNewswire/ — AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two…
Limited-edition collaboration brings together sustainability, Bay Area design, and local pride SAN FRANCISCO, April 12, 2026 /PRNewswire/ — SF Climate…